Testing effectiveness (Phase 2)Study completedNCT00750815
What this trial is testing
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)
Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 58